Here’s why patients need to be placed front and center when choosing antiretroviral therapy.
Here’s why I think the 3 most essential aspects when switching ART are treatment history, genetic barrier to resistance, and hearing what your patient is telling you.
Here are my thoughts on how the emergence of long-acting ART reflects the continued evolution of HIV treatment to better meet the broad needs of our patients and what ongoing research efforts may bring about for future long-acting ART options.
How soon should ART be initiated in patients who present with opportunistic infections, and what is the best regimen? In this commentary, I share my approach to starting ART in patients with advanced HIV and opportunistic infections.